Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7681)
All Articles published online
|
Dec 22, 2012 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Talib LL, Joaquim HP, Forlenza OV. Platelet biomarkers in Alzheimer’s disease. World J Psychiatr 2012; 2(6): 95-101 [PMID: 24175175 DOI: 10.5498/wjp.v2.i6.95] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v2/i6/95.htm |
| Number | Citing Articles |
| 1 |
Yi-Ling Chien, Hai-Gwo Hwu, Tzung-Jeng Hwang, Ming H. Hsieh, Chen-Chung Liu, Shoei-Yn Lin-Shiau, Chih-Min Liu. Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2020; 99: 109868 doi: 10.1016/j.pnpbp.2020.109868
|
| 2 |
David Pellerin, Artuela Çaku, Mathieu Fradet, Paméla Bouvier, Jean Dubé, François Corbin. Lovastatin corrects ERK pathway hyperactivation in fragile X syndrome: potential of platelet’s signaling cascades as new outcome measures in clinical trials. Biomarkers 2016; 21(6): 497 doi: 10.3109/1354750X.2016.1160289
|
| 3 |
Samir Kumar Beura, Rishika Dhapola, Abhishek Ramachandra Panigrahi, Pooja Yadav, Dibbanti Harikrishna Reddy, Sunil Kumar Singh. Redefining oxidative stress in Alzheimer's disease: Targeting platelet reactive oxygen species for novel therapeutic options. Life Sciences 2022; 306: 120855 doi: 10.1016/j.lfs.2022.120855
|
| 4 |
Ryszard Pluta, Barbara Miziak, Stanisław J. Czuczwar. Post-Ischemic Permeability of the Blood–Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer’s Disease-Type Brain Neurodegeneration. International Journal of Molecular Sciences 2023; 24(13): 10739 doi: 10.3390/ijms241310739
|
| 5 |
Kaiyu Wu, Chunyan Xu, Xiaoping Tian, Guozhen Qiu, Wei Liu, Qiwen Guo, Chunchun Chen, Jianjun Liu, Zhiwei Guo, Haifei Chen, Kangding Liu, Feiqi Zhu. Association between Alterations in Routine-Checked Blood Parameters and Cognitive Impairments in the Shenzhen Aging-Related Disorder Cohort in China. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4125474
|
| 6 |
David Pellerin, Audrey Lortie, François Corbin. Platelets as a surrogate disease model of neurodevelopmental disorders: Insights from Fragile X Syndrome. Platelets 2018; 29(2): 113 doi: 10.1080/09537104.2017.1317733
|
| 7 |
Isabella Wiest, Tim Wiemers, Max-Joseph Kraus, Heiko Neeb, Erwin F. Strasser, Lucrezia Hausner, Lutz Frölich, Peter Bugert. Multivariate Platelet Analysis Differentiates Between Patients with Alzheimer’s Disease and Healthy Controls at First Clinical Diagnosis. Journal of Alzheimer's Disease 2019; 71(3): 993 doi: 10.3233/JAD-190574
|
| 8 |
Wei Wei, Pan Xu, Li Li, Hong Mao, Na Li, Xiao-qing Wang, Li Wang, Zhi-peng Xu, Shi Zhao. Association of glycogen synthase kinase-3β with cognitive impairment in type 2 diabetes patients: a six-year follow-up study. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1386773
|
| 9 |
Marcos V. Pais, Orestes V. Forlenza, Breno S. Diniz. Plasma Biomarkers of Alzheimer’s Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice. Journal of Alzheimer's Disease Reports 2023; 7(1): 355 doi: 10.3233/ADR-230029
|
| 10 |
Yolanda Espinosa-Parrilla, Christian Gonzalez-Billault, Eduardo Fuentes, Ivan Palomo, Marcelo Alarcón. Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders. Frontiers in Aging Neuroscience 2019; 11 doi: 10.3389/fnagi.2019.00151
|
| 11 |
Velichka Strijkova, Svetla Todinova, Tonya Andreeva, Ariana Langari, Desislava Bogdanova, Elena Zlatareva, Nikolay Kalaydzhiev, Ivan Milanov, Stefka G. Taneva. Platelets’ Nanomechanics and Morphology in Neurodegenerative Pathologies. Biomedicines 2022; 10(9): 2239 doi: 10.3390/biomedicines10092239
|
| 12 |
Michael Veitinger, Balazs Varga, Sheila B Guterres, Maria Zellner. Platelets, a reliable source for peripheral Alzheimer’s disease biomarkers?. Acta Neuropathologica Communications 2014; 2(1) doi: 10.1186/2051-5960-2-65
|
| 13 |
Qing Wang, Yachen Shi, Xinyang Qi, Lingyu Qi, Xiang Chen, Jingping Shi, Chunming Xie, Zhijun Zhang. Platelet-Derived Amyloid-β Protein Precursor as a Biomarker of Alzheimer’s Disease. Journal of Alzheimer's Disease 2022; 88(2): 589 doi: 10.3233/JAD-220122
|
| 14 |
Daniela Ehrlich, Christian Humpel. Platelets in psychiatric disorders. World Journal of Psychiatry 2012; 2(6): 91-94 doi: 10.5498/wjp.v2.i6.91
|
| 15 |
Jessyka Maria de França Bram, Leda Leme Talib, Helena Passarelli Giroud Joaquim, Tamires Alves Sarno, Wagner Farid Gattaz, Orestes Vicente Forlenza. Protein levels of ADAM10, BACE1, and PSEN1 in platelets and leukocytes of Alzheimer’s disease patients. European Archives of Psychiatry and Clinical Neuroscience 2019; 269(8): 963 doi: 10.1007/s00406-018-0905-3
|
| 16 |
L. Clancy, J.E. Freedman. The role of circulating platelet transcripts. Journal of Thrombosis and Haemostasis 2015; 13: S33 doi: 10.1111/jth.12922
|
| 17 |
Gang Li, Dan Wang, Jing Zhao, Mei Zhou, Kang Wang, Shaohua Wu, Ling Lin. Improve the precision of platelet spectrum quantitative analysis based on “M+N” theory. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2022; 264: 120291 doi: 10.1016/j.saa.2021.120291
|
| 18 |
Samir K. Beura, Abhishek R. Panigrahi, Pooja Yadav, Siwani Agrawal, Sunil K. Singh. Role of Neurons and Glia Cells in Wound Healing as a Novel Perspective Considering Platelet as a Conventional Player. Molecular Neurobiology 2022; 59(1): 137 doi: 10.1007/s12035-021-02587-4
|
| 19 |
Eun Kyeong Yun, In‐Ho Seo, Hye Sun Lee, So‐Young Seol, Yong‐Jae Lee. Sex differences in the relationship between platelet count and type 2 diabetes risk in community‐dwelling adults: Longitudinal findings over 14 years. Diabetes/Metabolism Research and Reviews 2023; 39(6) doi: 10.1002/dmrr.3641
|
| 20 |
Nezha Bouhaddou, Meryem Mabrouk, Farah Atifi, Abdelhakim Bouyahya, Younes Zaid. The link between BDNF and platelets in neurological disorders. Heliyon 2024; 10(21): e39278 doi: 10.1016/j.heliyon.2024.e39278
|
| 21 |
Sayali Chandrashekhar Deolankar, Arun H. Patil, Devasahayam Arokia Balaya Rex, Pratigya Subba, Anita Mahadevan, Thottethodi Subrahmanya Keshava Prasad. Mapping Post-Translational Modifications in Brain Regions in Alzheimer's Disease Using Proteomics Data Mining. OMICS: A Journal of Integrative Biology 2021; 25(8): 525 doi: 10.1089/omi.2021.0054
|
| 22 |
Afrooz Arzehgar, Fatemeh Davarinia, Gordon A. Ferns, Ali Hakimi, Afsane Bahrami. Predicting the Cognitive Ability of Young Women Using a New Feature Selection Algorithm. Journal of Molecular Neuroscience 2023; 73(7-8): 678 doi: 10.1007/s12031-023-02145-8
|
| 23 |
Helena Colvee-Martin, Juan Rayo Parra, Gabriel Antonio Gonzalez, Warren Barker, Ranjan Duara. Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer’s Disease. Diagnostics 2024; 14(7): 704 doi: 10.3390/diagnostics14070704
|
| 24 |
Cristina M. Pedrero-Prieto, Javier Frontiñán-Rubio, Francisco J. Alcaín, Mario Durán-Prado, Juan R. Peinado, Yoana Rabanal-Ruiz. Biological Significance of the Protein Changes Occurring in the Cerebrospinal Fluid of Alzheimer’s Disease Patients: Getting Clues from Proteomic Studies. Diagnostics 2021; 11(9): 1655 doi: 10.3390/diagnostics11091655
|
| 25 |
Stefka G. Taneva, Svetla Todinova, Tonya Andreeva. Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 2023; 24(18): 14296 doi: 10.3390/ijms241814296
|
| 26 |
Simon M. Bell, Katy Barnes, Matteo De Marco, Pamela J. Shaw, Laura Ferraiuolo, Daniel J. Blackburn, Annalena Venneri, Heather Mortiboys. Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?. Biomedicines 2021; 9(1): 63 doi: 10.3390/biomedicines9010063
|
| 27 |
Federico A. Prestia, Pablo Galeano, Pamela V. Martino Adami, Sonia Do Carmo, Eduardo M. Castaño, A. Claudio Cuello, Laura Morelli. Platelets Bioenergetics Screening Reflects the Impact of Brain Aβ Plaque Accumulation in a Rat Model of Alzheimer. Neurochemical Research 2019; 44(6): 1375 doi: 10.1007/s11064-018-2657-x
|
| 28 |
Shengjie Zhao, Jun Zhao, Tong Zhang, Chunni Guo. Increased apoptosis in the platelets of patients with Alzheimer’s disease and amnestic mild cognitive impairment. Clinical Neurology and Neurosurgery 2016; 143: 46 doi: 10.1016/j.clineuro.2016.02.015
|
| 29 |
Hannah Melchinger, Kanika Jain, Tarun Tyagi, John Hwa. Role of Platelet Mitochondria: Life in a Nucleus-Free Zone. Frontiers in Cardiovascular Medicine 2019; 6 doi: 10.3389/fcvm.2019.00153
|
| 30 |
Claudia Tagliarini, Manuel Glauco Carbone, Giovanni Pagni, Donatella Marazziti, Nunzio Pomara. Is there a relationship between morphological and functional platelet changes and depressive disorder?. CNS Spectrums 2022; 27(2): 157 doi: 10.1017/S1092852920001959
|